Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC31H34N6O3 |
InChIKeyOYWGFOXQBJYTIR-DEOSSOPVSA-N |
CAS Registry3032393-24-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | United States | 02 Oct 2023 |





